Katalyze AI thinks the future of pharma operations is teams of AI agents

Katalyze AI announced $10.5 million USD ($14.9 million CAD) in seed funding on Monday to deploy its workflow software across large pharmaceutical firms. The news: Katalyze is building an agentic operating system for pharma firms. The startup’s platform allows pharma workers to build teams of AI agents to tackle engineering, scientific, and manufacturing tasks.